Medical Economics April 19, 2024
AI helps primary care physicians with the deprescription decision-making process
Researchers from the Mass General Brigham MESH Incubator have unearthed promising results in the use of artificial intelligence (AI) to manage polypharmacy and streamline deprescription processes.
The study, led by Arya Rao, a Harvard Medical student and MESH researcher, alongside senior corresponding author Dr. Marc Succi, evaluated the efficacy of ChatGPT, a generative AI chatbot, in medication management. Their findings, published on April 18th in the Journal of Medical Systems, mark a step forward in integrating AI into the complex landscape of health care decision-making.
Polypharmacy, rampant among older adults, elevates the risk of adverse drug interactions, necessitating careful deprescription to mitigate harm. Yet, this decision-making process is intricate and...
Today's Sponsors
Today's Sponsor